Clinical Trials Insight: 700050057

Trial Profile

Clinical Trials Insight: 700050057

Phase of Trial: Phase I

Latest Information Update: 20 Oct 2009

At a glance

  • Drugs MBX 2982 (Primary)
  • Indications Glucose intolerance; Type 2 diabetes mellitus
  • Focus Pharmacodynamics; Pharmacokinetics
  • Sponsors CymaBay Therapeutics
  • Most Recent Events

    • 20 Oct 2009 New trial record.
    • 13 Oct 2009 Results published in a Metabolex media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top